China CRO 2009 is a compilation of all global and local CROs operating in China as of April 30th, 2009. It lists 122 CROs in drug discovery, preclinical studies and clinical trials.
It excludes:
- CMOs in custom synthesis, pharmaceutical development and manufacturing unless they also offer CRO services
- SDFA-designated clinical trial sites and GLP-certified research institutes, unless they are operating as commercial entities
Modular's annual China CRO directory is generated from our proprietary CRO database, which includes detailed information about each CRO and is frequently updated for comprehensiveness and accuracy through primary and secondary research.
China CRO 2009 is the second edition of the China CRO directory.
We deliver China CRO 2009 by request to interested parties as a way to let the world know about our capabilities and to keep in touch with the international drug and medical device development community. Please credit Modular R&D and China CRO 2009™ when you use the directory and the data within, or when you share it with others.
We try to keep Modular lists comprehensive and accurate, and gratefully welcome additions and corrections. If you think your company meets the inclusion criteria but is absent from our list, please kindly inform us at research@modularrandd.com
For questions about this list, please contact us at research@modularrandd.com
To inquire about Modular’s services, please contact us at inquiries@modularrandd.com